Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study.

Chuanxin DuanWangji ZhouMiaoyan ZhangChongsheng ChengWenshuai XuJinrong DaiShuzhen MengKeqi ChenYang ZhaoSong LiuShao-Ting WangYanli YangKai-Feng XuXinlun Tian

Published in: Orphanet journal of rare diseases (2023)

aPAP patients with poor baseline respiration have a higher probability of hypoxia after COVID-19 infection, but fatal events were rare.

Keyphrases

pulmonary hypertension
multiple sclerosis
endothelial cells
drug induced